Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach.
about
Nanomedicine in the application of uveal melanomaEndostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluationTheranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers.Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapyImmune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycolNanocarrier-based immunotherapy in cancer management and research.Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.PEG-lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication.Modifying the tumor microenvironment using nanoparticle therapeuticsBiomimetic nanoassembly for targeted antigen delivery and enhanced Th1-type immune response.Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of LPS for combined chemo-immunotherapy.Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery.Carbohydrate-appended photocytotoxic (imidazophenanthroline)-oxovanadium(IV) complexes for cellular targeting and imaging.Bitargeting and ambushing nanotheranostics.Oxovanadium(IV) complexes of curcumin for cellular imaging and mitochondria targeted photocytotoxicity.
P2860
Q28079572-63549423-25AE-48BA-A25A-3781F28F6D2CQ34396694-7F6E4A77-08D3-4077-8449-6B14BF2338A6Q34698633-3B7A8881-6A32-47FA-9505-FD4C40488531Q35153705-659E1740-F27F-4B46-B6C3-9132EE465756Q36110892-B348730D-6A02-4FD4-9B3C-812639B4C786Q36427935-D282D10F-FE0C-481B-9DF8-92D4EE3481FDQ37031671-90E16A80-AF09-4335-BB8C-085FECBFAAB7Q37302933-1B3ECAF4-D2BA-446E-BE01-FDA52AD91C21Q38303124-F14B8756-812B-44B7-8564-F1DA846C8FE3Q38796320-7C3094A2-9EFE-4E6E-B8A1-2F0F87782986Q38834398-6CA10C91-7BC5-494F-9E8F-188B61519EEDQ38912004-6485C0EC-EE80-467B-9E89-6FF6CECA15CDQ39356108-0997043D-3A79-4335-9BA5-6F93459DD049Q43012179-4D08EBC9-081B-4A6E-9F35-FE6A85AF67FDQ45374290-6F07DC28-AF04-430E-B339-D57AC4AC4C94Q46223507-4D0B169F-3CB4-446E-9070-BFF110A696CDQ46860046-5D380ACA-B5EC-47D2-9D0F-72FA5334A9F1
P2860
Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Combined chemo-immunotherapy a ...... a nanoparticle based approach.
@en
Combined chemo-immunotherapy a ...... a nanoparticle based approach.
@nl
type
label
Combined chemo-immunotherapy a ...... a nanoparticle based approach.
@en
Combined chemo-immunotherapy a ...... a nanoparticle based approach.
@nl
prefLabel
Combined chemo-immunotherapy a ...... a nanoparticle based approach.
@en
Combined chemo-immunotherapy a ...... a nanoparticle based approach.
@nl
P356
P1476
Combined chemo-immunotherapy a ...... a nanoparticle based approach
@en
P2093
Manu Smriti Singh
Pramod Upadhyay
P304
P356
10.1021/MP100153R
P407
P577
2010-09-16T00:00:00Z